share_log

HC Wainwright & Co. Maintains Buy on CASI Pharmaceuticals, Lowers Price Target to $10

HC Wainwright & Co. Maintains Buy on CASI Pharmaceuticals, Lowers Price Target to $10

HC Wainwright & Co.维持对CASI Pharmicals的买入,将目标价下调至10美元
Benzinga Real-time News ·  2022/11/15 06:18

HC Wainwright & Co. analyst Sean Lee maintains CASI Pharmaceuticals (NASDAQ:CASI) with a Buy and lowers the price target from $12 to $10.

HC Wainwright & Co. 分析师肖恩·李维持CASI Pharmicals(纳斯达克股票代码:CASI)的买入,并将目标股价从12美元下调至10美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发